New Approvals – Page 8 – media

Aimovig a New Drug for Migraines Gets Approval from FDA

Aimovig, a ground-breaking drug to prevent Migraines was approved by the FDA last week. Aimovig will be the only player in the market to treat migraines. The new drug has to be taken once a month through an injection similar to an insulin shot or an EpiPen.
- Source: Ddu
- 644
- May 21, 2018
FDA migraine New Approvals
New rapid Rabies test- LN34; developed by U.S Center for Disease Control

Rabies takes nearly 60,000 lives each year; it is deadly if not treated early. Regions like Africa and Asia are at higher risk. LN34 is believed to make screening faster and better test to avoid the weeks-long series of shots now given to prevent the disease for the people exposed to potentially rabid. The test, done on suspect animals, can be run on platforms which are already used to screen for the flu, tuberculosis, and HIV.
- Source: Ddu
- 932
- May 18, 2018
New Approvals pharmaceutical rabies
FDA Approves Qiagen’s PartoSure for Preterm Labor

On April 20, 2018, Qiagen announced the FDA approval of the novel test named PartoSureTM, used for assessing the risk of spontaneous preterm birth in patients with symptoms of preterm labor.
- Source: Ddu
- 637
- May 17, 2018
medical device New Approvals preterm labor
New Sensor Detects Arsenic Contamination in One Min

Scientists from the Department of Chemistry at Imperial have developed a small, user-friendly, accurate and cost-effective sensor to test arsenic levels in drinking water within a minute. When a drop of water hits the test strip, it gives the arsenic level count digitally.
- Source: Ddu
- 744
- May 17, 2018
arsenic trioxide medical device New Approvals
FDA approved Pfizer biosimilar Epogen/Procrits

The FDA granted approval to Pfizer for Retacrit (epoetin alfa-epbx), which is used for the treatment of anemia, biosimilar of Amgen, a drug which generated sales closely $ 1.8 billion in the U.S market last year for Amgen and Johnson & Johnson partners. Retacrit also received the go-ahead to be used in RBC transfusions by U.S health regulators.
- Source: Ddu
- 682
- May 16, 2018
anemia New Approvals Pfizer pharma
Remote eICU program launched to monitor patients health in US Hospitals

Providing an advanced technological paradigm to patient monitoring practices, a telemedicine platform has been launched in Australia. The remote intensive care partnership will enable doctors and nurses at the Royal Perth Hospital on the western coast of Australia to explore telemedicine technology to assess patient health in US hospitals that form part of the hub-and-spoke telehealth network of Emory.
- Source: Ddu
- 714
- May 16, 2018
digital health New Approvals Telemedicine
Amsterdam airport to be a new site for EU CAR-T manufacturing facility of Gilead

When it comes to manufacturing CAR T drugs (personalized treatments engineering immune cells to destroy cancer cells of patients) speed is of utmost importance. A new manufacturing site has been decided upon by Gilead for Yescarta, its CAR-T therapy at a Netherlands airport.
- Source: drugdu
- 665
- May 16, 2018
cancer CAR T-cells FDA New Approvals
Experimental Merck vaccine gears up to fight Congo Ebola outbreak

As the Democratic Republic of Congo deals with a rising death toll owing to the latest outbreak of Ebola, health officials are moving fast to counter the fatal effects of the deadly virus. Plans are afoot to implement the experimental vaccine developed by Merck & Co to confront the overwhelming challenges posed by the virus.
- Source: Ddu
- 718
- May 15, 2018
Ebola Merck New Approvals vaccines
Medibio releases new app on Apple Watch, links biometric markers to overall health

Last week Medibio, a company focused on how biometric markers impact mental health, launched a new app that integrates with the Apple Watch. The app works with the watch to collect biometrics, such as heart rate and then lets users see these markers in conjunction with their mental and overall health.
- Source: Mobi Health News
- 673
- May 15, 2018
Mental health mHealth New Approvals
3 Ways 3D Printing Is Changing the Medical Field

Every year, 3D printing offers more and more promise in the healthcare field. And while the ultimate goal of printing whole complex organs for transplants may still be decades away, 3D printing is helping to save and improve lives in ways - and in places - never imagined just a few years ago.
- Source: ASME
- 689
- May 14, 2018
3D printing New Approvals

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.